AT207346T

Oral pharmaceutical compositions containing sex hormones

Abstract

(57) Are a composite for medicines which consists of composition below a summary, and Hydrophobic medicine, The digestibility oil chosen from any of triglyceride of fatty acid of inside chain length (C*C) and/, or long chain length (C*C) or propylene glycol ester, and the lauric acid monoester of propylene glycol, It consists of hydrophilic interface active agents consisting of the oleophilic surface-active agent consisting of glyceride of C*C fatty acid, and polyoxyethylene hydrogenation castor oil, It is a composite for medicines which consists of this digestibility oil existing to the weight of a composite in the range up to 3.0 to 12.0 % of the weight, and the weight rate of a hydrophilic interface active agent to an oleophilic surface-active agent being in the range of 1: 1.5 to 1: 2.5. As a suitable hydrophobic medicine, sex hormone, for example, progesterone, oestradiol, and testosterone are mentioned.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

17 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
9608719United KingdomA
9701247United KingdomW

Members17

Family members, oldest first
DocumentOfficeKind
GB9608719D0United KingdomD0
WO9740823A1World Intellectual Property Organization (WIPO)A1
AU2707497AAustraliaA
ZA973653BSouth AfricaB
EP0904064A1European Patent Office (EPO)A1
JP2000510458AJapanA
KR20000065025ARepublic of KoreaA
EP0904064B1European Patent Office (EPO)B1
AT207346TThis recordAustriaT
ATE207346T1AustriaT1
DE69707669D1GermanyD1
DK0904064T3DenmarkT3
ES2164339T3SpainT3
PT904064EPortugalE
DE69707669T2GermanyT2
KR100511133B1Republic of KoreaB1
JP5088804B2JapanB2